Added to YB: 2025-04-02
Pitch date: 2025-02-12
PHX.AX [bullish]
Pharmx Technologies Limited
+5%
current return
Author Info
No bio for this author
Company Info
Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand.
Market Cap
AUD 58.0M
Pitch Price
AUD 0.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
-37.73
P/E
-29.54
EV/Sales
7.34
Sector
Software
Category
growth
PharmX Technologies Limited - $PHX.AX
PHX.AX: Critical B2B EDI for Aus healthcare, 99% pharmacy use, $20B+ transactions. New mgmt fixing undermonetization (0.035% take rate), modernizing tech, launching marketplace. 20% EDI growth, 75% EBITDA margin. Marketplace upside w/ partners like MCoBeauty. Risks: tech disruption, execution. Catalysts: clean financials, PharmXchange traction.
Read full article (19 min)